Publications

immunologic markers of progression to acquired immunodeficiency syndrome are time-dependent and illness-specific.	since prevalent cohorts may be biased by the duration of human immunodeficiency virus (hiv) infection (onset bias), it is useful to assess the potential predictive value of markers in incident cohorts of hiv-positive subjects for whom the date of seroconversion is known or can reliably be estimated. of 131 homosexual men with hiv-1 seroconversion from new york city and washington, dc, who were evaluated annually beginning in 1982, 60 developed acquired immunodeficiency syndrome (aids) by the end ...	1992	1384311
forecasts of the costs of medical care for persons with hiv: 1992-1995.	this study concludes that the cumulative (national) cost of treating all persons with the human immunodeficiency virus (hiv) rose considerably over the past year and will continue to rise over the next several years. it is forecast that the cumulative cost of treating all persons with hiv will increase 48% from 1992 to 1995 (from $10.3 billion to $15.2 billion). it is estimated that the average yearly cost of treating a person with aids is $38,300 and of treating an infected person without aids ...	1992	1356925